Vertex 'Correction' to Cystic Fibrosis Destroys Billions in Value (VRTX)

Health and Healthcare

Published: May 29, 2012 8:04 am

Last Updated: April 28, 2020 9:18 am

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was very close to 52-week highs of late, but that will not be the case now. The company updated information that is being called a correction about lung function from its Phase 2 trial of the company’s VX-809 and KALYDECO in cystic fibrosis patients.

The new and corrected data indicated that only 35% of patients experienced an absolute improvement in their lung function of at least 5% versus the previously reported statistic of 46% of patients experiencing absolute improvement in lung function. Vertex also said that only 19% had at least a 10% improvement when they were treated with VX-809 and KALYDECO versus a prior report that 30% saw at least 10% improvement. Those who were treated with VX-809 and KALYDECO experienced an 8.5% mean absolute improvement in lung function versus patients treated with placebo.

Apparently this correction is due to a misinterpretation of third party vendor data. Vertex closed at $64.85 on Friday against a 52-week trading range of $26.50 to $66.10. Shares are trading down 18% at $53.01 so far this morning and about 150,000 shares have already traded hands with more than 90 minutes until the market opens.

To let you know just what this means in market value, Vertex had a market cap of $13.7 billion as of Friday’s close. If the drop remains static then almost $2.5 billion in market value will have been destroyed by this “correction” to the data.

JON C. OGG

The Average American Has No Idea How Much Money You Can Make Today ^(Sponsor)

The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.

But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.

Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

¹https://www.fdic.gov/national-rates-and-rate-caps